-
2024-511702-23-00
Congenital adrenal hyperplasia 4 2025-08-05
-
2024-514143-28-00
Mild autonomous cortisol secretion 6 2025-08-01
-
2024-514846-35-00
CONGENITAL ADRENAL HYPERPLASIA 4 2025-07-22
-
2023-508322-10-00
Cushing Syndrome 4 2025-05-02
-
2024-516753-45-00
ROHHAD syndrome 4 2025-04-25
-
2023-509450-55-01
Type 1 Diabetes Mellitus with chronic kidney complicati 4 2025-04-01
-
2023-505854-16-00
47,XXY (Klinefelter syndrome) 6 2025-04-01
-
2024-515511-21-00
Neuroendocrine Carcinoma / G3 Neuroendocrine Tumours 4 2025-03-13
-
2022-502164-20-01
obesity 6 2025-03-11
-
2024-516813-19-00
central diabetes insipidus 4 2025-02-26
-
2024-512628-12-00
Primary aldosteronism 10 2025-01-28
-
2023-506211-18-00
Postmenopausal women with previous breast cancer or cu 5 2025-01-09
-
2023-508254-26-00
Primary aldosteronism 7 2024-11-06
-
2024-517611-67-00
papillary craniopharyngioma 4 2024-11-01
-
2023-508093-28-00
Healthy 4 2024-10-20
-
2024-514505-64-01
Polycystic ovary syndrome 11 2024-10-18
-
2023-504446-58-00
Type 2 diabetes, chronic kidney disease 6 2024-10-15
-
2024-516755-40-00
paragangliomas 4 2024-09-27
-
2024-511009-50-00
Precocious puberty
and overweight 4 2024-08-27
-
2024-517110-15-00
Hyperthyroidism 5 2024-08-15
-
2023-504898-20-00
Thyroid neoplasms:
● Cohort 1: Advanced radioactive-iod 4 2024-07-30
-
2023-505794-32-04
Type 1 diabetes 5 2024-07-05
-
2024-510637-18-00
Postmenopausal osteoporosis 6 2024-05-21
-
2023-505116-37-00
Obesity 4 2024-02-08